Industry Experts

Alexey Kadet, currently Chief Business officer at Crownlands, has pioneered product and commercialization strategies at the intersection of human data, AI/ML, and biology since the early days of AI for Drug Discovery. He also has led several industry-first transactions focused on biology of aging and age-related diseases. Currently at Crownlands, his focus is to enable development of neurodegenerative disease medicines by leveraging Gateway — the world's largest single-cell neuronal dataset, collected entirely from living patients.